Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations
Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Journal Of Viral Hepatitis 2008, 15: 69-72. PMID: 18837839, DOI: 10.1111/j.1365-2893.2008.01034.x.Peer-Reviewed Original ResearchConceptsRecommendation of vaccinationAnti-HAV antibodiesVaccine-preventable infectionsImmunoglobulin G antibodiesYears of ageLow endemicity regionsEnzyme-linked immunosorbentWorld Health OrganizationUniversal hepatitisIntermediate endemicityVaccination recommendationsHepatitis AOverall prevalenceVaccination policyMedical CenterMass vaccinationImmunization policyAge groupsVaccinationHealth OrganizationSocioeconomic differencesHepatitisEndemicityHygiene conditionsAgeCytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children.
Tezer H, Seçmeer G, Kara A, Ceyhan M, Cengiz AB, Devrim I, Us D, Yüce A, Gürakan F, Yildirim I, Ozen H, Saltik-Temizel IN. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. The Turkish Journal Of Pediatrics 2008, 50: 228-34. PMID: 18773667.Peer-Reviewed Original ResearchConceptsBiliary atresiaGanciclovir treatmentCauses of hepatitisCongenital CMV infectionExtrahepatic biliary atresiaSigns of infectionCMV hepatitisCholestatic hepatitisCMV infectionCytomegalovirus infectionImmunocompetent childrenStudy groupHepatitisPatientsGroup IIDemographic featuresGroup IInborn errorsInfectionAtresiaChildrenTreatmentGroupGenetic diseasesCMV